In atherosclerosis, miR-146a exhibits anti-inflammatory properties by inhibiting the NF-κB pathway and regulating cytokine expression, including IL-6, IL-8, IL-17 and TNFα. The gene discussed is NFKB1; the disease is atherosclerosis.